The pharmaceutical Sector in India is at the crossroads. Having established itself as the world leader in the space of generics—accounting for one-fifth of the global generic export volume (IBEF)—it has begun to take the
Much before the Union Budget was unveiled, Indian pharmaceutical and medical device manufacturers were granted significant competitive privileges over their foreign counterparts.
